-
Je něco špatně v tomto záznamu ?
Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen
P. Vrbata, P. Berka, D. Stránská, P. Doležal, M. Musilová, L. Čižinská,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antiflogistika nesteroidní aplikace a dávkování chemie MeSH
- aplikace sublinguální MeSH
- lékové transportní systémy * MeSH
- nanovlákna chemie MeSH
- naproxen aplikace a dávkování chemie MeSH
- prasata MeSH
- sumatriptan aplikace a dávkování chemie MeSH
- techniky in vitro MeSH
- ústní sliznice metabolismus MeSH
- vazokonstriktory aplikace a dávkování chemie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Sublingual administration of active pharmaceutical substances is in principle favourable for rapid onset of drug action, ready accessibility and avoidance of first pass metabolism. This administration could prove very useful in the treatment of migraines, thus two frequently used drugs were selected for our study. Sumatriptan succinate, naproxen, and its salt as well as combinations of these were incorporated into nanofibrous membranes via the electrospinning process. DSC measurements proved that the resulted membranes contained non-crystalline drug forms. SEM imaging approved good homogeneity of diameter and shape of the membrane nanofibres. The nanofibrous membranes always showed the rapid and mutually independent release of the tested drugs. The drugs exhibited very high differences in sublingual permeation rates in vitro, but the rates of both substances were increased several times using nanofibrous membranes as the drug carrier in comparison to drug solutions. The released drugs subsequently permeated through sublingual mucosa preferentially as non-ionized moieties. The prepared nanofibrous membranes proved very flexible and mechanically resistant. With their drug load capacity of up to 40% of membrane mass, they could be very advantageous for the formulation of sublingual drug delivery systems.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063961
- 003
- CZ-PrNML
- 005
- 20250312123818.0
- 007
- ta
- 008
- 140704s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2013.08.085 $2 doi
- 035 __
- $a (PubMed)24050988
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vrbata, Petr $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech Republic.
- 245 10
- $a Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen / $c P. Vrbata, P. Berka, D. Stránská, P. Doležal, M. Musilová, L. Čižinská,
- 520 9_
- $a Sublingual administration of active pharmaceutical substances is in principle favourable for rapid onset of drug action, ready accessibility and avoidance of first pass metabolism. This administration could prove very useful in the treatment of migraines, thus two frequently used drugs were selected for our study. Sumatriptan succinate, naproxen, and its salt as well as combinations of these were incorporated into nanofibrous membranes via the electrospinning process. DSC measurements proved that the resulted membranes contained non-crystalline drug forms. SEM imaging approved good homogeneity of diameter and shape of the membrane nanofibres. The nanofibrous membranes always showed the rapid and mutually independent release of the tested drugs. The drugs exhibited very high differences in sublingual permeation rates in vitro, but the rates of both substances were increased several times using nanofibrous membranes as the drug carrier in comparison to drug solutions. The released drugs subsequently permeated through sublingual mucosa preferentially as non-ionized moieties. The prepared nanofibrous membranes proved very flexible and mechanically resistant. With their drug load capacity of up to 40% of membrane mass, they could be very advantageous for the formulation of sublingual drug delivery systems.
- 650 _2
- $a aplikace sublinguální $7 D000286
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika nesteroidní $x aplikace a dávkování $x chemie $7 D000894
- 650 12
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a ústní sliznice $x metabolismus $7 D009061
- 650 _2
- $a nanovlákna $x chemie $7 D057139
- 650 _2
- $a naproxen $x aplikace a dávkování $x chemie $7 D009288
- 650 _2
- $a sumatriptan $x aplikace a dávkování $x chemie $7 D018170
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a vazokonstriktory $x aplikace a dávkování $x chemie $7 D014662
- 650 _2
- $a techniky in vitro $7 D066298
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Berka, Pavel $7 _AN057583
- 700 1_
- $a Stránská, Denisa
- 700 1_
- $a Doležal, Pavel
- 700 1_
- $a Musilová, Marie
- 700 1_
- $a Čižinská, Lucie
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 457, č. 1 (2013), s. 168-76
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24050988 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20250312123825 $b ABA008
- 999 __
- $a ok $b bmc $g 1031445 $s 862693
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 457 $c 1 $d 168-76 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20140704